| |
| |
|
| Insider
Information: |
Anderson Bonnie H |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
75,036 |
|
|
Indirect Shares
|
156,523 |
|
|
| Direct
Value |
$1,525,804 |
|
|
|
Indirect Value
|
$2,829,452 |
|
|
| Total
Shares |
231,559 |
|
|
| Total
Value |
$4,355,256 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -33.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Director |
2023-06-02 |
41,377 |
2023-06-02 |
134,800 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2019-07-29 |
23,630 |
2020-07-17 |
21,723 |
Premium* |
|
|
Bruker Corp |
BRKR |
|
2024-01-05 |
10,029 |
2020-09-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
162 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-01-10 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
137,738 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-01-10 |
4 |
AS |
$28.86 |
$577,276 |
D/D |
(20,000) |
117,738 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
267,738 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(39,488) |
228,250 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
261,250 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,937) |
256,313 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
AS |
$25.18 |
$503,520 |
D/D |
(20,000) |
256,313 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
276,313 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-03-20 |
4 |
OE |
$2.68 |
$42,880 |
D/D |
16,000 |
272,313 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-04-30 |
4 |
AS |
$30.09 |
$90,737 |
I/I |
(3,000) |
34,723 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,870 |
274,183 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-05-11 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
294,183 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-05-11 |
4 |
AS |
$26.66 |
$533,334 |
D/D |
(20,000) |
274,183 |
0 |
% |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-05-12 |
4 |
AS |
$35.00 |
$140,000 |
I/I |
(4,000) |
30,723 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-06-02 |
4 |
D |
$26.01 |
$51,396 |
D/D |
(1,976) |
272,207 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-06-10 |
4 |
OE |
$4.00 |
$80,000 |
D/D |
20,000 |
292,207 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-06-10 |
4 |
AS |
$26.56 |
$531,260 |
D/D |
(20,000) |
272,207 |
0 |
% |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-06-15 |
4 |
AS |
$40.00 |
$240,000 |
I/I |
(6,000) |
24,723 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-16 |
4/A |
AS |
$42.90 |
$130,659 |
I/I |
(3,000) |
21,723 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2020-07-17 |
4 |
AS |
$42.90 |
$130,659 |
I/I |
(3,000) |
21,723 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-20 |
4 |
OE |
$4.00 |
$171,287 |
D/D |
20,349 |
292,556 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-20 |
4 |
AS |
$32.04 |
$651,911 |
D/D |
(20,349) |
272,207 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-21 |
4 |
OE |
$8.86 |
$30,540 |
D/D |
3,447 |
275,654 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-21 |
4 |
AS |
$32.09 |
$110,614 |
D/D |
(3,447) |
272,207 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chairman and CEO |
• • – |
2020-07-22 |
4 |
OE |
$8.86 |
$886 |
D/D |
100 |
272,307 |
0 |
- |
|
162 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
